Zhehai Wang Selected Research

Zhehai Wang Research Topics

Disease

43	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 10/2003
20	Neoplasms (Cancer) 12/2023 - 03/2012
7	Disease Progression 05/2024 - 01/2018
5	Adenocarcinoma of Lung 02/2024 - 01/2015
5	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2013
4	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2016
4	Hypertension (High Blood Pressure) 01/2021 - 11/2018
3	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2016
3	Diarrhea 01/2022 - 01/2014
2	Exanthema (Rash) 01/2022 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2019
2	Neutropenia 01/2021 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2014
2	Hand-Foot Syndrome 01/2019 - 11/2018
2	Adenocarcinoma 01/2017 - 05/2016
2	Breast Neoplasms (Breast Cancer) 02/2015 - 02/2013
1	Thrombocytopenia (Thrombopenia) 03/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Thymoma (Thymic Carcinoma) 08/2021
1	Leukopenia 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Hypertriglyceridemia 01/2019
1	Hypothyroidism 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Paronychia 01/2019
1	Hyponatremia 11/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Constipation 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Malignant Pleural Effusion 01/2018
1	Weight Loss (Weight Reduction) 02/2017
1	Proteinuria 01/2017
1	Esophageal Squamous Cell Carcinoma 01/2016

Drug/Important Bio-Agent (IBA)

9	anlotinibIBA 05/2022 - 01/2018
7	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2016
6	Immune Checkpoint InhibitorsIBA 01/2024 - 02/2020
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2014
5	apatinibIBA 06/2022 - 09/2013
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2003
4	Anaplastic Lymphoma KinaseIBA 05/2024 - 01/2018
4	Docetaxel (Taxotere)FDA Link 04/2023 - 02/2017
4	PlatinumIBA 01/2022 - 10/2012
4	Pemetrexed (MTA)FDA Link 01/2021 - 10/2012
3	CrizotinibIBA 05/2024 - 01/2023
3	sintilimabIBA 04/2023 - 01/2021
3	B7-H1 AntigenIBA 01/2023 - 01/2021
3	camrelizumabIBA 12/2022 - 01/2021
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2016
3	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2016
3	AntigensIBA 12/2014 - 03/2012
3	Chimeric Antigen ReceptorsIBA 09/2014 - 03/2012
2	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2021
2	LigandsIBA 12/2022 - 01/2018
2	Gefitinib (Iressa)FDA Link 01/2022 - 02/2015
2	aumolertinibIBA 01/2022 - 01/2022
2	AntibodiesIBA 08/2021 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2014
2	Leucovorin (Folinic Acid)FDA Link 01/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 10/2003
2	Gemcitabine FDA Link 10/2012 - 10/2012
1	alectinibIBA 05/2024
1	serum P-component (CIt)IBA 03/2024
1	oprelvekin (Neumega)FDA Link 03/2024
1	human ERBB2 proteinIBA 01/2024
1	sitravatinibIBA 01/2023
1	tislelizumabIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Circulating Tumor DNAIBA 12/2022
1	atezolizumabIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	APTIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019
1	Cortisone FDA Link 01/2019
1	CMAB009IBA 01/2019
1	Fibric Acids (Fibrates)IBA 01/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2018
1	Blood Glucose (Blood Sugar)IBA 11/2018
1	Triglycerides (Triacylglycerol)IBA 11/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	human TNFSF10 proteinIBA 01/2018
1	icotinibIBA 02/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2017
1	Mitogen-Activated Protein KinasesIBA 02/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2016
1	Estrogen ReceptorsIBA 02/2015
1	Tamoxifen FDA LinkGeneric 02/2015

Therapy/Procedure

25	Therapeutics 03/2024 - 10/2003
21	Drug Therapy (Chemotherapy) 03/2024 - 05/2002
9	Immunotherapy 03/2024 - 03/2012
3	Radiotherapy 01/2019 - 05/2002
2	Chemoradiotherapy 01/2018 - 01/2016
1	Platelet Transfusion (Blood Platelet Transfusions) 03/2024
1	Precision Medicine 02/2023
1	Folfox protocol 01/2019